Insider Trading & Ownership - Lewis Karen

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Lewis Karen
Common stock purchase or sale:
Transaction
Date		 Reported
DateTime		 Company Symbol Insider
Relationship		 Shares
Traded		 Average
Price		 Total
Amount		 Shares
Owned		 Filing
2025-01-29
Sale		 2025-01-30
12:12 pm		 Apellis Pharmaceuticals Inc. APLS Lewis Karen
Chief People Officer		 364 $29.52 $10,747 70,251
(Direct)		 View
2025-01-22
Sale		 2025-01-23
3:29 pm		 Apellis Pharmaceuticals Inc. APLS Lewis Karen
Chief People Officer		 1,751 $30.43 $53,275 70,615
(Direct)		 View
2025-01-17
Sale		 2025-01-21
4:07 pm		 Apellis Pharmaceuticals Inc. APLS Lewis Karen
Chief People Officer		 1,241 $29.96 $37,178 72,366
(Direct)		 View
2025-01-13
Sale		 2025-01-14
4:20 pm		 Apellis Pharmaceuticals Inc. APLS Lewis Karen
Chief People Officer		 1,599 $28.7 $45,895 45,099
(Direct)		 View
2024-01-29
Sale		 2024-01-31
4:28 pm		 Apellis Pharmaceuticals Inc. APLS Lewis Karen
Chief People Officer		 1,250 $65.12 $81,402 46,387
(Direct)		 View
2024-01-23
Sale		 2024-01-24
4:06 pm		 Apellis Pharmaceuticals Inc. APLS Lewis Karen
Chief People Officer		 4,286 $63.69 $272,975 47,637
(Direct)		 View
2024-01-22
Sale		 2024-01-23
6:07 pm		 Apellis Pharmaceuticals Inc. APLS Lewis Karen
Chief People Officer		 1,738 $65 $112,963 51,923
(Direct)		 View
2024-01-17
Sale		 2024-01-18
4:54 pm		 Apellis Pharmaceuticals Inc. APLS Lewis Karen
Chief People Officer		 3,276 $65.58 $214,840 53,661
(Direct)		 View
2024-01-16
Sale		 2024-01-17
4:43 pm		 Apellis Pharmaceuticals Inc. APLS Lewis Karen
Chief People Officer		 1,632 $66.81 $109,032 81,603
(Direct)		 View
2023-06-01
Sale		 2023-06-02
4:40 pm		 Apellis Pharmaceuticals Inc. APLS Lewis Karen
Chief People Officer		 5,000 $86 $430,000 147,504
(Direct)		 View
2023-04-03
Sale		 2023-04-05
4:52 pm		 Apellis Pharmaceuticals Inc. APLS Lewis Karen
Chief People Officer		 5,000 $75 $375,000 152,430
(Direct)		 View
2023-02-23
Sale		 2023-02-27
4:32 pm		 Apellis Pharmaceuticals Inc. APLS Lewis Karen
Chief People Officer		 1,104 $68.76 $75,911 41,430
(Direct)		 View
2023-01-30
Sale		 2023-01-31
4:47 pm		 Apellis Pharmaceuticals Inc. APLS Lewis Karen
Chief People Officer		 883 $52.76 $46,587 36,459
(Direct)		 View
2023-01-23
Sale		 2023-01-25
4:17 pm		 Apellis Pharmaceuticals Inc. APLS Lewis Karen
Chief People Officer		 2,955 $51.58 $152,419 37,709
(Direct)		 View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date		 Reported
DateTime		 Exercisable
Expiration		 Company Symnbol Insider
Relationship		 Shares
Traded		 Conversion
Price		 Shares
Owned		 Filing
2025-01-21
Option Award		 2025-01-21
4:07 pm		 N/A
N/A		 Apellis Pharmaceuticals Inc. APLS Lewis Karen
Chief People Officer		 28,508 $0 72,366
(Direct)		 View
2024-01-16
Option Award		 2024-01-17
4:43 pm		 N/A
2034-01-15		 Apellis Pharmaceuticals Inc. APLS Lewis Karen
Chief People Officer		 24,666 $66.3 81,603
(Direct)		 View
2024-01-16
Option Award		 2024-01-17
4:43 pm		 N/A
N/A		 Apellis Pharmaceuticals Inc. APLS Lewis Karen
Chief People Officer		 16,963 $0 81,603
(Direct)		 View
2023-06-01
Exercise		 2023-06-02
4:40 pm		 N/A
N/A		 Apellis Pharmaceuticals Inc. APLS Lewis Karen
Chief People Officer		 5,000 $34.11 147,504
(Direct)		 View
2023-06-01
Exercise		 2023-06-02
4:40 pm		 N/A
2030-05-03		 Apellis Pharmaceuticals Inc. APLS Lewis Karen
Chief People Officer		 5,000 $0 147,504
(Direct)		 View
2023-04-03
Exercise		 2023-04-05
4:52 pm		 N/A
N/A		 Apellis Pharmaceuticals Inc. APLS Lewis Karen
Chief People Officer		 5,000 $34.11 152,430
(Direct)		 View
2023-04-03
Exercise		 2023-04-05
4:52 pm		 N/A
2030-05-03		 Apellis Pharmaceuticals Inc. APLS Lewis Karen
Chief People Officer		 5,000 $0 152,430
(Direct)		 View
2023-02-21
Tax Withholding		 2023-02-22
06:50 am		 N/A
N/A		 Apellis Pharmaceuticals Inc. APLS Lewis Karen
Chief People Officer		 553 $58.5 51,936
(Direct)		 View
2023-02-21
Option Award		 2023-02-22
06:50 am		 N/A
2033-01-20		 Apellis Pharmaceuticals Inc. APLS Lewis Karen
Chief People Officer		 16,030 $0 51,936
(Direct)		 View
2023-01-27
Tax Withholding		 2023-01-30
5:01 pm		 N/A
N/A		 Apellis Pharmaceuticals Inc. APLS Lewis Karen
Chief People Officer		 367 $52.77 37,342
(Direct)		 View
2023-01-20
Tax Withholding		 2023-01-24
5:20 pm		 N/A
N/A		 Apellis Pharmaceuticals Inc. APLS Lewis Karen
Chief People Officer		 1,411 $52.05 40,664
(Direct)		 View
2022-04-25
Other		 2023-01-17
7:39 pm		 N/A
2031-01-27		 Apellis Pharmaceuticals Inc. APLS Lewis Karen
Chief People Officer		 8,750 $0 74,170
(Direct)		 View
2023-01-12
Option Award		 2023-01-17
7:39 pm		 N/A
2033-01-11		 Apellis Pharmaceuticals Inc. APLS Lewis Karen
Chief People Officer		 30,845 $52.66 74,170
(Direct)		 View
2023-01-12
Option Award		 2023-01-17
7:39 pm		 N/A
N/A		 Apellis Pharmaceuticals Inc. APLS Lewis Karen
Chief People Officer		 19,634 $0 74,170
(Direct)		 View
2022-01-28
Tax Withholding		 2022-02-01
5:59 pm		 N/A
N/A		 Apellis Pharmaceuticals Inc. APLS Lewis Karen
Chief People Officer		 434 $38.59 23,474
(Direct)		 View
2022-01-21
Option Award		 2022-01-25
4:40 pm		 N/A
2032-01-20		 Apellis Pharmaceuticals Inc. APLS Lewis Karen
Chief People Officer		 42,240 $0 48,682
(Direct)		 View
2021-01-28
Option Award		 2021-02-01
4:37 pm		 N/A
2031-01-27		 Apellis Pharmaceuticals Inc. APLS Lewis Karen
Chief People Officer		 43,750 $0 43,750
(Direct)		 View

Ownership		 2020-06-09
6:07 pm		 N/A
2030-05-03		 Apellis Pharmaceuticals Inc. APLS Lewis Karen
Chief People Officer		 0 $0 116,000
(Direct)		 View